Your browser doesn't support javascript.
loading
The global landscape of bladder cancer incidence and mortality in 2020 and projections to 2040.
Zhang, Yanting; Rumgay, Harriet; Li, Mengmeng; Yu, Haibing; Pan, Haiyan; Ni, Jindong.
Afiliação
  • Zhang Y; Department of Epidemiology and Health Statistics, School of Public Health, Guangdong Medical University, Dongguan, China.
  • Rumgay H; Cancer Surveillance Branch, International Agency for Research on Cancer, Lyon, France.
  • Li M; Department of Cancer Prevention, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Sun Yat-sen University Cancer Center, Guangzhou, China.
  • Yu H; Department of Epidemiology and Health Statistics, School of Public Health, Guangdong Medical University, Dongguan, China.
  • Pan H; Department of Epidemiology and Health Statistics, School of Public Health, Guangdong Medical University, Dongguan, China.
  • Ni J; Department of Epidemiology and Health Statistics, School of Public Health, Guangdong Medical University, Dongguan, China.
J Glob Health ; 13: 04109, 2023 Sep 15.
Article em En | MEDLINE | ID: mdl-37712386
ABSTRACT

Background:

Bladder cancer (BCa) is one of the most common urological malignancies worldwide. This study examines the global epidemiological profile of BCa incidence and mortality in 2020 and the projected burden to 2040.

Methods:

The estimated number of BCa cases and deaths were extracted from the GLOBOCAN 2020 database. Age-standardised incidence rates (ASIRs) and age-standardised mortality rates (ASMRs) were calculated using the world standard. The predicted BCa incidence and mortality in 2040 was calculated based on demographic projections.

Results:

Globally, approximately 573 000 new BCa cases and 213 000 deaths occurred in 2020, corresponding to ASIRs and ASMRs of 5.6 and 1.9 per 100 000, respectively. The incidence and mortality rates were approximately 4-fold higher in men (9.5 and 3.3 per 100 000, respectively) than women (2.4 and 0.9, respectively). Across world regions, incidence rates varied at least 12-fold among men and 8-fold among women, with the highest ASIRs for both men and women detected in Southern Europe (26.5 and 5.8 per 100 000, respectively) and Western Europe (21.5 and 5.8, respectively) and the lowest in Middle Africa (2.2) in men and South-Central Asia (0.7) in women. The highest ASMRs for both men and women were found in Northern Africa (9.2 and 1.8 per 100 000, respectively). By 2040, the annual number of new BCa cases and deaths will increase to 991 000 (72.8% increase from 2020) and 397 000 (86.6% increase), respectively.

Conclusions:

Geographical distributions of BCa incidence and mortality uncovered higher risk of BCa incidence in Southern and Western European populations and higher risk of mortality in Northern African populations. Considering the predicted 73% and 87% increase in annual BCa cases and deaths by 2040 globally, respectively, there is an urgent need to develop and accelerate BCa control initiatives for high-risk populations to tackle global BCa burden and narrow its geographical disparities.
Assuntos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias da Bexiga Urinária Tipo de estudo: Incidence_studies / Prognostic_studies / Risk_factors_studies Limite: Female / Humans / Male País/Região como assunto: Africa / Asia Idioma: En Revista: J Glob Health Ano de publicação: 2023 Tipo de documento: Article País de afiliação: China

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias da Bexiga Urinária Tipo de estudo: Incidence_studies / Prognostic_studies / Risk_factors_studies Limite: Female / Humans / Male País/Região como assunto: Africa / Asia Idioma: En Revista: J Glob Health Ano de publicação: 2023 Tipo de documento: Article País de afiliação: China